Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates

medRxiv(2020)10.1101/2020.08.07.20170456Source: DataRank Database

Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (23)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Andrew Sieben ORCID,Kristin Nelson ORCID,Alicia N.M. Kraay ORCID,Ben Lopman,Andreas Handel ORCID

Live enrichment

PubMed:32817958 OpenAlex:https://openalex.org/W3048548243

National Institutes of Health

Grant: 3R01GM124280-03S1

Preparing for the SARS-CoV2 vaccine: Modeling of transmission pathways, viral evolution and vaccination strategies

National Science Foundation

Grant: 2032084

Collaborative Research: RAPID: Integrative Modeling of Intervention Serology and the Role of Shield Immunity in Reducing COVID-19 Epidemic Spread

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/08/11/2020.08.07.20170456.full.pdf

GREENhttps://www.nature.com/articles/s41591-020-01172-x.pdf

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/08/11/2020.08.07.20170456.full.pdf

repositoryhttps://doi.org/10.1101/2020.08.07.20170456

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32817958

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesVaccine Coverage and HesitancyMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

VaccinationContext (archaeology)MedicineVaccine efficacyCoronavirus disease 2019 (COVID-19)PopulationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical trialImmunologyEnvironmental healthVirologyIntensive care medicineBiologyDiseaseInfectious disease (medical specialty)Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being